Product Program year 2025 Source: CMS Open Payments

Galzin

Drug Metabolics

NDC 71863-124-25

Open in the dashboard

General payments

$20,549

148 payments

Research payments

$0

0 payments

Through program year 2025, $20,549 in general payments and $0 in research payments were reported against Galzin (Metabolics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $20,549 148

Breakdown

Who paid General payments · program year 2025
  1. Eton Pharmaceuticals, Inc. $20,549 148 payments
Top recipients General payments · program year 2025
  1. Edward Tabor Pediatrics · Bethesda, MD $5,160 25% · 1 payment
  2. Sammy Saab Gastroenterology · Los Angeles, CA $3,000 15% · 1 payment
  3. Valentina Medici Gastroenterology · Sacramento, CA $2,000 10% · 1 payment
  4. Hrishikesh Samant Gastroenterology · Shreveport, LA $1,025 5% · 1 payment
  5. Prasun Jalal Transplant Hepatology · Houston, TX $1,000 5% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Gastroenterology Internal Medicine $7,511 37% · 20 practitioners
  2. Pediatrics $5,396 26% · 12 practitioners
  3. Transplant Hepatology Internal Medicine $2,131 10% · 8 practitioners
  4. Hepatology Internal Medicine $1,582 8% · 6 practitioners
  5. Pediatric Gastroenterology Pediatrics $1,151 6% · 24 practitioners

The top 5 of 21 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $7,175 35% · 11 recipients
  2. Maryland $6,278 31% · 7 recipients
  3. Texas $2,071 10% · 47 recipients
  4. Florida $1,385 7% · 17 recipients
  5. Louisiana $1,074 5% · 3 recipients

The top 5 of 23 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

148 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record